Wang Li-Dong, Zheng Shu, Zheng Zuo-Yu, Casson Alan G
Cancer Institute, Zhejiang University, Hangzhou 310009, Jiangsu Province, China.
World J Gastroenterol. 2003 Jun;9(6):1156-64. doi: 10.3748/wjg.v9.i6.1156.
Gastric cardia adenocarcinoma (GCA) is an under-studied subject. The pathogenesis, molecular changes in the early stage of carcinogenesis and related risk factors have not been well characterized. There is evidence, however, that GCA differs from cancer of the rest of the stomach in terms of natural history and histopathogenesis. Adenocarcinomas of the lower esophagus, esophagogastric junction (EGJ) and gastric cardia have been given much attention because of their increasing incidences in the past decades, which is in striking contrast with the steady decrease in distal stomach adenocarcinoma. In China, epidemiologically, GCA shares very similar geographic distribution with esophageal squamous cell carcinoma (SCC), especially in Linzhou (formerly Linxian County), Henan Province, North China, the highest incidence area of esophageal SCC in the world. Historically, both GCA and SCC in these areas were referred to as esophageal cancer (EC) by the public because of the common syndrome of dysphagia. In Western countries, Barrett's esophagus is very common and has been considered as an important precancerous lesion of adenocarcinoma at EGJ. Because of the low incidence of Barrett's esophagus in China, it is unlikely to be an important factor in early stage of EGJ adenocarcinoma development. However, Z line up-growth into lower esophagus may be one of the characteristic changes in these areas in early stage of GCA development. Whether intestinal metaplasia (IM) is a premalignant lesion for GCA is still not clear. Higher frequency of IM observed at adjacent GCA tissues in Henan suggests the possibility of IM as a precancerous lesion for GCA in these areas. Molecular information on GCA, especially in early stage, is very limited. The accumulated data about the changes of tumor suppressor gene, such as p53 mutation, and ontogeny, such as C-erbB2, especially the similar alterations in GCA and SCC in the same patient, indicated that there might be some similar risk factors, such as nitrosamine, involved in both GCA and SCC in Henan population. The present observations also suggest that GCA should be considered as a distinct entity.
贲门腺癌(GCA)是一个研究较少的课题。其发病机制、癌变早期的分子变化及相关危险因素尚未得到充分阐明。然而,有证据表明,GCA在自然史和组织病理学发生方面与胃其他部位的癌症不同。由于过去几十年中食管下段、食管胃交界(EGJ)和贲门腺癌的发病率不断上升,它们受到了广泛关注,这与远端胃腺癌发病率的稳步下降形成了鲜明对比。在中国,从流行病学角度来看,GCA与食管鳞状细胞癌(SCC)具有非常相似的地理分布,尤其是在华北河南省林州(原林县),这是世界上食管SCC发病率最高的地区。从历史上看,由于吞咽困难这一共同症状,这些地区的GCA和SCC在公众中都被称为食管癌(EC)。在西方国家,巴雷特食管非常常见,被认为是EGJ腺癌的重要癌前病变。由于中国巴雷特食管的发病率较低,它不太可能是EGJ腺癌早期发展的重要因素。然而,Z线向上生长至食管下段可能是这些地区GCA早期发展的特征性变化之一。肠化生(IM)是否为GCA的癌前病变仍不清楚。在河南,GCA相邻组织中观察到的IM频率较高,提示IM在这些地区可能是GCA的癌前病变。关于GCA的分子信息,尤其是早期的信息非常有限。关于肿瘤抑制基因变化(如p53突变)和个体发育(如C-erbB2)的累积数据,特别是同一患者GCA和SCC中的相似改变,表明河南人群中可能存在一些共同的危险因素,如亚硝胺,同时涉及GCA和SCC。目前的观察结果还表明,GCA应被视为一个独特的实体。